Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2001;49:462-463; doi:10.1136/gut.49.4.462
Copyright © 2001 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2001;49:462-463 ( October )

Commentary

See article on page 488

Counting the cost of proton pump inhibitors

The first 150 words of the full text of this article appear below.

Proton pump inhibitors (PPIs) have become an indispensable part of the armoury of treating gastro-oesophageal reflux disease (GORD). They are more effective than H2 receptor antagonists and prokinetic agents in oesophagitis and endoscopy negative reflux disease.1 This efficacy comes at a price however and PPIs are the most expensive class of drug in the UK, costing nearly £300 million in 1998.2 There have been attempts to curb PPI expenditure and the UK National Institute for Clinical Excellence has issued guidelines on appropriate prescription.2

The problem is that there is a dearth of health economic data to inform those making health care decisions. Economic models have suggested that PPIs are cost effective therapy for GORD but there have been criticisms of this approach3 and they do not address the root of the problem. Economic decisions are simple when a drug that is more expensive and less effective is compared with a . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery
H E Myrvold, L Lundell, P Miettinen, S A Pedersen, B Liedman, J Hatlebakk, R Julkunen, K Levander, M Lamm, C Mattson, J Carlsson, N O Ståhlhammar, and Nordic GORD Study Group
Gut 2001 49: 488-494. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Mahmood, Z, McMahon, B P, Arfin, Q, Byrne, P J, Reynolds, J V, Murphy, E M, Weir, D G (2003). Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut 52: 34-39 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs